Merck Archives

$BIXT Spikes on Delayed Reaction to the Most Powerful Drug Since Penicillin

Bioxytran Inc. (OTCMKTS: BIXT) is perhaps one of the most undervalued biotechs in OTC. There is a real chance that if this...

512

1

Biotech

Monkeypox Stocks Heating Up the Charts: TOMDF APDN CODX

Investors are facing the sober reality of a twin pandemic, COVID-19, and monkeypox. It’s now clear that the government missed the opportunity...

884

1

Biotech

Glaxo’s New Focus After Haleon Spinoff Shines a Light on CytoDyn (OTCMKTS: CYDY) as a Takeover Target

GSK (NYSE: GSK) has a new mission and that mission is to go after major medical conditions that have no treatment. The...

1.6K

Biotech

Todos (OTCMKTS: TOMDF) CEO Nails NewsMax Interview With Critical Messages About the Pandemic

This Saturday Todos Medical’s (OTCMKTS: TOMDF) CEO set the stage for future international media exposure. This interview was powerful, gripping, and informative...

737

Biotech

Why Todos Medical (OTCMKTS: TOMDF) is Running Ahead of the Pack

Todos Medical (OTCMKTS: TOMDF) was a value play before it started running recently based on sound fundamental analysis, and now investors are...

578

Biotech

The 3CL Secret to Pfizer’s and Todos Medical’s Success

Pfizer’s (NYSE: PFE) PAXLOVID has risen to prominence as the top COVID-19 antiviral in the world. The speed at which they rose...

703

1

Biotech

Picking a Bottom in CytoDyn – Right Now

CytoDyn Inc (OTCMKT: CYDY) has been under considerable selling pressure since April and nothing seems to be able to stop it. In...

2.0K

Biotech

Atea Failure Leaves Todos Medical (TOMDF) Last Man Standing in Oral Antivirals

The big news circulating this week was of Atea Pharmaceuticals’ (NASDAQ: AVIR) COVID-19 antiviral clinical trial failure, which instantly plummeted the stock...